My coach is excellent. He is helping me with my A1C, cortisol, and weight loss journey.
Foundayo™ Pill with Ongoing Care
A once-daily oral GLP-1 pill with up to ~11% average weight loss at 72 weeks in Phase 3 clinical trials. Prescribed through Healthspan Membership with clinician-led evaluation and ongoing care to manage dosing, labs, and long-term metabolic health.
Your clinician reviews your medical history, goals, and biomarkers to determine eligibility. If prescribed, medication is billed separately and fulfilled through a licensed pharmacy.
Your care team manages dosing and tolerance, reviews labs, and provides guidance on nutrition and strength to support safe, sustainable progress.
Regular check-ins and labs track 70+ biomarkers beyond weight, including metabolic health, body composition, lean muscle, and sleep.
NEW ORAL GLP-1
Foundayo™ is now available as a once-daily oral pill
FDA-approved oral GLP-1
Easy, once-daily pill
~11% average weight loss at 72 weeks in Phase 3 trials
No injections or refrigeration needed
Prescription & ongoing care through Healthspan
1 In Phase 3 trial of adults without diabetes taking the highest dose of Foundayo™ (orforglipron) alongside diet and exercise. Individual results may vary.
How ongoing care shapes GLP-1 outcomes
2x
Longer on therapy
Ongoing support keeps patients on GLP-1s 2x longer, maximizing long-term benefits
9+
Systems affected
GLP-1s influence brain, heart, kidney, & more. Tracking biomarkers across these systems enables better care
85%+
Muscle mass preserved
With guidance, patients preserve lean muscle through targeted protein and strength protocols
0-6 mo.
Critical adjustment period
Early months require guidance for dosing, tolerance, & progress for long-term success
Most GLP-1 programs stop at the prescription
Ours starts there
your complete care
Your personalized GLP-1 care starts with membership
Patient voices
I speak with the Healthspan team monthly about my protocols and their effects on my bloodwork (which I do quarterly). I've seen dramatic improvement in my A1C, LDL, and overall health. The results are remarkable.
Clinician-guided GLP-1 treatment
Your clinician reviews your medical history and goals to determine eligibility and guide the right treatment choice, including injectable or oral options.
Supporting brain function
GLP-1s cross the blood–brain barrier and have been studied for effects on neuroinflammation, mood regulation, and cognitive resilience, with early evidence suggesting neuroprotective potential.
Protecting cardiovascular health
Large outcome trials show reductions in major adverse cardiac events, linked to improved endothelial function, lower inflammation, and favorable lipid and blood pressure changes.
Supporting kidney function
GLP-1s have been associated with reduced albuminuria and slower progression of diabetic kidney disease in some populations.
Improving liver health
GLP-1s are well studied in NAFLD and NASH, with evidence showing reductions in liver fat and improvements in insulin sensitivity and liver enzymes.
Supporting PCOS & fertility
GLP-1 therapy has been associated with improvements in insulin resistance, ovulatory function, and androgen levels in individuals with PCOS, with emerging evidence for fertility benefits.
Reducing chronic inflammation
GLP-1 signaling has been linked to lower systemic inflammation, including reductions in CRP and improvements in endothelial and neuroinflammatory markers.
Improving body composition
GLP-1s influence fat loss and visceral fat reduction while impacting appetite regulation and metabolic efficiency; preserving lean mass remains a key clinical consideration.
Supporting respiratory health
Tirzepatide has been studied for weight-related obstructive sleep apnea, showing clinically meaningful reductions in apnea–hypopnea index.
Hear from our patients
Frequently asked questions
Healthspan offers an online, clinician-led GLP-1 care program designed for more than weight loss alone. A licensed clinician reviews your medical history, symptoms, and goals to determine whether Foundayo™ is appropriate for you. If prescribed, care continues with personalized dosing, side-effect management, and ongoing support as your body adapts. Medication is filled separately through the pharmacy. Your Healthspan membership covers clinical oversight and a care model designed to support safe, effective GLP-1 use over time.
Foundayo™ (orforglipron) is an oral GLP-1 receptor agonist taken as a pill, rather than an injection. Like injectable GLP-1s, it helps regulate appetite, metabolic function, and insulin signaling. The key difference is delivery: Foundayo™ is taken orally, while traditional GLP-1s are injected weekly. Because absorption and dosing differ, Healthspan provides clinician-guided dosing, side-effect management, and ongoing support to help ensure therapy is used safely and effectively over time.
The GLP-1 membership is designed to support GLP-1 therapy as ongoing medical care, not a one-time prescription. Membership includes clinician evaluation and prescribing, personalized dosing and titration over time, and continued clinical oversight as your body responds to treatment. Members also receive support for side-effect management, nutrition as appetite changes, and muscle-preservation strategies to support long-term metabolic health. The membership includes ongoing biomarker and lifestyle tracking, with labs incorporated into care when clinically appropriate to monitor metabolic health and guide treatment decisions over time. Labs are not required to start treatment, but are an important part of Healthspan’s longevity-focused approach as therapy progresses. Membership starts at $99 per month. GLP-1 medications are billed separately based on the prescription and pharmacy used. As part of the membership, Healthspan helps coordinate prescriptions, refills, and medication logistics as treatment evolves.
No. Healthspan clinicians prescribe GLP-1 therapy to support broader metabolic and long-term health goals, including: - Metabolic health and insulin sensitivity - Cardiometabolic risk reduction - Appetite regulation and energy balance - Long-term health and aging-related outcomes Your clinician evaluates your goals and health context to determine whether Foundayo™ is appropriate.
Yes. Many members come to Healthspan after starting a GLP-1 elsewhere. A licensed clinician reviews your current medication, dosing history, tolerance, and goals to determine whether switching to Foundayo™ makes sense. If appropriate, your clinician guides the transition, including dose adjustments and side-effect management, to support a smooth change.
Like other GLP-1 medications, Foundayo™ may cause side effects, particularly early in treatment or during dose increases. Common side effects may include: - Nausea - Gastrointestinal discomfort - Changes in appetite - Feeling full more quickly These effects are typically temporary and improve as the body adjusts. Healthspan’s care model includes gradual titration, clinician guidance, and personalized adjustments to help minimize side effects and support long-term success.
Healthspan offers an online, clinician-led GLP-1 care program designed for more than weight loss alone. A licensed clinician reviews your medical history, symptoms, and goals to determine whether Foundayo™ is appropriate for you. If prescribed, care continues with personalized dosing, side-effect management, and ongoing support as your body adapts. Medication is filled separately through the pharmacy. Your Healthspan membership covers clinical oversight and a care model designed to support safe, effective GLP-1 use over time.
Foundayo™ (orforglipron) is an oral GLP-1 receptor agonist taken as a pill, rather than an injection. Like injectable GLP-1s, it helps regulate appetite, metabolic function, and insulin signaling. The key difference is delivery: Foundayo™ is taken orally, while traditional GLP-1s are injected weekly. Because absorption and dosing differ, Healthspan provides clinician-guided dosing, side-effect management, and ongoing support to help ensure therapy is used safely and effectively over time.
The GLP-1 membership is designed to support GLP-1 therapy as ongoing medical care, not a one-time prescription. Membership includes clinician evaluation and prescribing, personalized dosing and titration over time, and continued clinical oversight as your body responds to treatment. Members also receive support for side-effect management, nutrition as appetite changes, and muscle-preservation strategies to support long-term metabolic health. The membership includes ongoing biomarker and lifestyle tracking, with labs incorporated into care when clinically appropriate to monitor metabolic health and guide treatment decisions over time. Labs are not required to start treatment, but are an important part of Healthspan’s longevity-focused approach as therapy progresses. Membership starts at $99 per month. GLP-1 medications are billed separately based on the prescription and pharmacy used. As part of the membership, Healthspan helps coordinate prescriptions, refills, and medication logistics as treatment evolves.
No. Healthspan clinicians prescribe GLP-1 therapy to support broader metabolic and long-term health goals, including: - Metabolic health and insulin sensitivity - Cardiometabolic risk reduction - Appetite regulation and energy balance - Long-term health and aging-related outcomes Your clinician evaluates your goals and health context to determine whether Foundayo™ is appropriate.
Yes. Many members come to Healthspan after starting a GLP-1 elsewhere. A licensed clinician reviews your current medication, dosing history, tolerance, and goals to determine whether switching to Foundayo™ makes sense. If appropriate, your clinician guides the transition, including dose adjustments and side-effect management, to support a smooth change.
Like other GLP-1 medications, Foundayo™ may cause side effects, particularly early in treatment or during dose increases. Common side effects may include: - Nausea - Gastrointestinal discomfort - Changes in appetite - Feeling full more quickly These effects are typically temporary and improve as the body adjusts. Healthspan’s care model includes gradual titration, clinician guidance, and personalized adjustments to help minimize side effects and support long-term success.